<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635680"><TermName>DTIC-Dome</TermName><TermDefinition><DefinitionText>A drug used to treat Hodgkin lymphoma and malignant melanoma. It is also being studied in the treatment of other types of cancer. DTIC-Dome attaches to DNA in cells and may kill cancer cells. It is a type of alkylating agent. Also called dacarbazine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000734631" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;DTIC-Dome&quot;" language="en" id="_3"/><SpanishTermName>DTIC-Dome</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el linfoma de Hodgkin y el melanoma maligno. También está en estudio para el tratamiento de otros tipos de cáncer. DTIC-Dome se une al ADN de las células y puede destruir células cancerosas. Es un tipo de alquilante. También se llama dacarbazina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished><DateLastModified>2015-09-10</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000649947">Dacarbazine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
